Balt’s Post

During the development of the Safe-Decon Bio Pro units, multiple top-tier institutions across the country were invited to test the system in various applications and environments. The New York Department of Health, Albany Medical Center, and the University of Florida conducted rigorous testing on our units using different types of infectious waste, including COVID-19 and resistant bacterial spores. These studies were conducted independent of our involvement to confirm the integrity of the findings, and each institution used their own methodologies and equipment, introducing variables to the system that tested its robustness. The variety of applications allowed us to gather data on the versatility of the Bio Pro unit and verify the system’s effectiveness with a wide range of environments and users. Across the board, results were promising, with each institution confirming the effectiveness of the Bio Pro System. To learn more, download the published report: https://lnkd.in/eKh5MXpj

Live! Global PFM Diagnostic Tools Conference The main objectives of this conference are to present key finding, global trends, and insights from the latest Stocktaking of PFM Diagnostic Tools Report, developed by the PEFA Secretariat team, and discuss how PFM diagnostic tools could contribute to the actual development and strengthening of PFM systems at country level. It will also present opportunity to demo / introduce some of the tools. The event is primarily intended for all interested in PFM tools. It includes PEFA partners staff and consultants, government officials, other development partners, other PFM practitioners, policymakers, and academics, who work on strengthening PFM capacity and systems at country, regional, and global levels.

Each person is affected by EMF differently. And organ's are affected differently as well. The EMF Summit starts October 3rd. If you still don't think EMFs are NOT a problem, then I cannot help you. Register for the summit https://lnkd.in/enJJbej3 #emfwithyun

How ready are public sector facilities in offering H-IUD and DMPA-SC as part of expanded method choice and increased level of awareness and demand for high quality H-IUD and DMPA-SC information and services? A H-IUD demand creation focus webinar coming up.

🧬 Want Accurate Bacterial Identification? 🧬 Discover the best tools for precise 16S rRNA-based bacterial identification in my latest video! I compare EzTaxon vs. NCBI so you can choose the right database for your research and boost your results' accuracy. 🔬 🎥 Watch here: https://lnkd.in/dZWey7fy

Validation and Comparison of Frailty Indexes: An OHDSI Network Study #OHDSISocialShowcase #JoinTheJourney Lead: Chen Yanover Team: Louisa H. Smith, Tal El-Hay, Brianne Olivieri-Mui, PhD, MPH, Maytal Bivas-Benita, Rob Cavanaugh, Pinchas Akiva, Chelsea N Wong, Ariela Orkaby Background: A frailty index (FI) is a marker of overall health status and vulnerability, often used to identify those at increased risk for adverse health outcomes, such as hospitalization, disability, or death. It is typically calculated as a sum (or proportion) of health indicators – or deficits – across diverse health domains including chronic conditions, physical function, cognition, mental health, nutrition, and social participation. FIs vary in the number and type of included deficits, depending on the data source and intended application, with a minimum recommendation of 30 deficits. In this exploratory project, we sought to validate and compare three electronic health record (EHR) FIs and one questionnaire-based FI across multiple healthcare settings and geographies, to understand the degree of frailty variability by FI metrics and geographic cohort. FIs were computed from individuals’ diagnoses, prescriptions, procedures, and devices. We calculated FIs (and the contributing deficits) from five data sources, two from the UA and three from the UK. https://lnkd.in/eCzP9YFR

https://lnkd.in/enURnZVx Tomorrow a very interesting webinar on the treatment of T1 CRCs. Two great speakers who go into detail on local excision techniques and new development of histological risk assessment. Looking forward to the discussion on the expanding indications for local excision and follow-up. #BarbaraBastiaansen #AndreaTannapfel

The latest CHIRP's Annual Digest of Reports and Insight Articles is here! 📰 Read it now or download it for later via the link below. #maritimesafety #safetyatsea

🤔 RCT, should we complement this approach? Randomized Controlled Trials (RCTs) compare outcomes between a treatment group and a control group to determine the impact of an intervention. The control group serves as a comparison to mimic what would have happened in the absence of the intervention (the counterfactual). RCTs can compare different versions of the same program or different programs addressing the same issue. They simulate an alternative universe where the intervention doesn't exist to gauge its true effects. 💡 It is always interesting to complement this approach with qualitative methods. ☑ They will allow you to understand the causal chain that got you to the impact, to understand what is causing it and how it is being caused. And moreover, they will give you clues on under which conditions the program worked.